116 related articles for article (PubMed ID: 21839250)
1. Long-term prognostic implications of metabolic syndrome in heart transplant recipients.
Sánchez-Lázaro IJ; Sánchez-Gómez JM; Almenar-Bonet L; Martínez-Dolz L; Muño-Giner B; Portolés-Sanz M; Roselló-Lleti E; Cortés-Vergaz R; Rivera-Otero M; Salvador-Sanz A
Transplant Proc; 2011; 43(6):2257-9. PubMed ID: 21839250
[TBL] [Abstract][Full Text] [Related]
2. Diabetes as an outcome predictor after heart transplantation.
Saraiva J; Sola E; Prieto D; Antunes MJ
Interact Cardiovasc Thorac Surg; 2011 Nov; 13(5):499-504; discussion 504. PubMed ID: 21835844
[TBL] [Abstract][Full Text] [Related]
3. Pulmonary hypertension in heart transplantation: discrepant prognostic impact of pre-operative compared with 1-year post-operative right heart hemodynamics.
Gude E; Simonsen S; Geiran OR; Fiane AE; Gullestad L; Arora S; Relbo A; Andreassen AK
J Heart Lung Transplant; 2010 Feb; 29(2):216-23. PubMed ID: 19837606
[TBL] [Abstract][Full Text] [Related]
4. Influence of metabolic syndrome on development of cardiac allograft vasculopathy in the transplanted heart.
Sánchez-Gómez JM; Martínez-Dolz L; Sánchez-Lázaro I; Almenar L; Sánchez-Lacuesta E; Muñoz-Giner B; Portolés M; Rivera M; Valera-Román A; González-Juanatey JR; Tejada-Ponce D; Agüero J; Buendía F; Salvador A
Transplantation; 2012 Jan; 93(1):106-11. PubMed ID: 22134367
[TBL] [Abstract][Full Text] [Related]
5. Metabolic syndrome in heart transplantation: impact on survival and renal function.
Martínez-Dolz L; Sánchez-Lázaro IJ; Almenar-Bonet L; Portolés M; Rivera M; Salvador A; Montero JA
Transpl Int; 2013 Sep; 26(9):910-8. PubMed ID: 23879350
[TBL] [Abstract][Full Text] [Related]
6. The impact of overweight on the development of diabetes after heart transplantation.
Kahn J; Rehak P; Schweiger M; Wasler A; Wascher T; Tscheliessnigg KH; Müller H
Clin Transplant; 2006; 20(1):62-6. PubMed ID: 16556155
[TBL] [Abstract][Full Text] [Related]
7. Effect of metabolic syndrome on clinical outcomes of non-diabetic peritoneal dialysis patients in India.
Prasad N; Sinha A; Gupta A; Sharma RK; Kaul A; Bhadauria D; Ranagswamy D
Nephrology (Carlton); 2013 Oct; 18(10):657-64. PubMed ID: 23834643
[TBL] [Abstract][Full Text] [Related]
8. Effects of obesity surgery on the metabolic syndrome.
Lee WJ; Huang MT; Wang W; Lin CM; Chen TC; Lai IR
Arch Surg; 2004 Oct; 139(10):1088-92. PubMed ID: 15492149
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of metabolic syndrome among Filipino adults aged 20 years and over.
Tanchoco CC; Cruz AJ; Duante CA; Litonjua AD
Asia Pac J Clin Nutr; 2003; 12(3):271-6. PubMed ID: 14505989
[TBL] [Abstract][Full Text] [Related]
10. Impact of different definitions of the metabolic syndrome on the prevalence of organ damage, cardiometabolic risk and cardiovascular events.
Mancia G; Bombelli M; Facchetti R; Casati A; Ronchi I; Quarti-Trevano F; Arenare F; Grassi G; Sega R
J Hypertens; 2010 May; 28(5):999-1006. PubMed ID: 20308922
[TBL] [Abstract][Full Text] [Related]
11. Bezafibrate for the secondary prevention of myocardial infarction in patients with metabolic syndrome.
Tenenbaum A; Motro M; Fisman EZ; Tanne D; Boyko V; Behar S
Arch Intern Med; 2005 May; 165(10):1154-60. PubMed ID: 15911729
[TBL] [Abstract][Full Text] [Related]
12. Early prediction of new-onset diabetes mellitus by fifth-day fasting plasma glucose, pulse pressure, and proteinuria.
Rodrigo E; Santos L; Piñera C; Quintanar JA; Ruiz JC; Fernández-Fresnedo G; Palomar R; Gómez-Alamillo C; Arias M
Transplant Proc; 2011; 43(6):2208-10. PubMed ID: 21839235
[TBL] [Abstract][Full Text] [Related]
13. Impact of the metabolic syndrome on long-term outcomes in simultaneous kidney-pancreas transplantation.
Rogers J; Stratta RJ; Lo A; Alloway RR
Transplant Proc; 2005 Oct; 37(8):3549-51. PubMed ID: 16298657
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of metabolic syndrome in heart transplant patients: role of previous cardiopathy and years since the procedure--the TRACA study.
Cordero Fort A; Gavira JJ; Alegría-Barrero E; Castaño S; Martín A; Ubilla M; Mastrobuoni S; Alegría Ezquerra E; Herreros J; Rábago G
J Heart Lung Transplant; 2006 Oct; 25(10):1192-8. PubMed ID: 17045931
[TBL] [Abstract][Full Text] [Related]
15. Determinants of serum HDL-C level in a Tehran urban population: the Tehran Lipid and Glucose Study.
Azizi F; Raiszadeh F; Salehi P; Rahmani M; Emami H; Ghanbarian A; Hajipour R
Nutr Metab Cardiovasc Dis; 2002 Apr; 12(2):80-9. PubMed ID: 12189907
[TBL] [Abstract][Full Text] [Related]
16. Application of three-dimensional body scanner: observation of prevalence of metabolic syndrome.
Lin JD; Chiou WK; Weng HF; Fang JT; Liu TH
Clin Nutr; 2004 Dec; 23(6):1313-23. PubMed ID: 15556253
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of metabolic syndrome in the Mediterranean region of Turkey: evaluation of hypertension, diabetes mellitus, obesity, and dyslipidemia.
Gündogan K; Bayram F; Capak M; Tanriverdi F; Karaman A; Ozturk A; Altunbas H; Gökce C; Kalkan A; Yazici C
Metab Syndr Relat Disord; 2009 Oct; 7(5):427-34. PubMed ID: 19754305
[TBL] [Abstract][Full Text] [Related]
18. Factors predicting 10-year survival after heart transplantation.
Radovancevic B; Konuralp C; Vrtovec B; Radovancevic R; Thomas CD; Zaqqa M; Vaughn WK; Frazier OH
J Heart Lung Transplant; 2005 Feb; 24(2):156-9. PubMed ID: 15701430
[TBL] [Abstract][Full Text] [Related]
19. Risk factor analysis of late survival after heart transplantation according to donor profile: a multi-institutional retrospective study of 512 transplants.
Fiorelli AI; Branco JN; Dinkhuysen JJ; Oliveira Junior JL; Pereira TV; Dinardi LF; Santos MM; Dias RR; Pereira LA; Stolf NA
Transplant Proc; 2012 Oct; 44(8):2469-72. PubMed ID: 23026622
[TBL] [Abstract][Full Text] [Related]
20. Uric acid as a link between renal dysfunction and both pro-inflammatory and prothrombotic state in patients with metabolic syndrome and coronary artery disease.
Zapolski T; Waciński P; Kondracki B; Rychta E; Buraczyńska MJ; Wysokiński A
Kardiol Pol; 2011; 69(4):319-26. PubMed ID: 21523662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
